Multicomponent Delivery Systems for Polyanionic Cargo
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene delivery systems, including viral and nonviral methods, face limitations such as immune response concerns, rapid clearance, and inefficient targeting of organs like the lungs, liver, and spleen, which hinder the therapeutic effectiveness of nucleic acids.
Innovation Solution
Development of multicomponent delivery systems comprising lipidated cationic peptoid components, combined with anionic or zwitterionic components and shielding agents, to form complexes with polyanionic cargo compounds like nucleic acids, enhancing delivery efficiency and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viral vectors are used for gene delivery, then delivery efficiency is improved, but immune response and safety concerns worsen
Solution Approach 1:
The patent uses nonviral delivery systems (lipid nanoparticles, polymers) that are transient and do not integrate into the genome, avoiding persistent immune responses while achieving sufficient delivery efficiency for therapeutic effect
Solution Approach 2:
The invention combines multiple nonviral components (cationic lipids, PEGylated lipids, cholesterol, siRNA) into composite lipid nanoparticle structures that achieve viral-level delivery efficiency without triggering the same immune responses
2Productivity
If viral delivery systems are used, then transfection efficiency is improved, but clearance from circulation worsens
Solution Approach 1:
The patent modifies physical parameters of the delivery system by using PEGylated lipids to increase hydrodynamic radius and reduce opsonization, thereby extending circulation half-life while maintaining transfection efficiency through optimized lipid composition and particle size
3Object-affected harmful factors
If nonviral delivery systems are used, then immune response is reduced, but delivery efficiency worsens
Solution Approach 1:
The cationic lipid component performs multiple functions simultaneously: complexing with nucleic acids through electrostatic interaction, facilitating cellular uptake through membrane interaction, and enabling endosomal escape through pH-dependent structural changes, thereby achieving high delivery efficiency with nonviral systems
4Productivity
If viral vectors are used, then gene delivery is achieved, but reversion to wild-type occurs
Solution Approach 1:
The patent extracts and uses only the beneficial transfection capability of viral systems while removing the dangerous integrating and replicating functions by employing nonviral delivery vectors that cannot revert or replicate, ensuring safety while maintaining delivery efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The multicomponent delivery systems improve the efficiency and stability of nucleic acid delivery, reducing immune responses and achieving targeted uptake in various tissues, enabling effective therapeutic applications.
Implementation Method 1
multicomponent delivery systems comprising at least one lipidated cationic peptoid component for the delivery of polyanionic compounds
Data Source
AI summary
The present disclosure relates to multicomponent delivery systems for delivering polyanionic cargo compounds, such as nucleic acids. The present disclosure also relates to methods of preparing and using the multicomponent delivery systems.